BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9129154)

  • 1. ESX: a structurally unique Ets overexpressed early during human breast tumorigenesis.
    Chang CH; Scott GK; Kuo WL; Xiong X; Suzdaltseva Y; Park JW; Sayre P; Erny K; Collins C; Gray JW; Benz CC
    Oncogene; 1997 Apr; 14(13):1617-22. PubMed ID: 9129154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An ERK2 docking site in the Pointed domain distinguishes a subset of ETS transcription factors.
    Seidel JJ; Graves BJ
    Genes Dev; 2002 Jan; 16(1):127-37. PubMed ID: 11782450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. External control of Her2 expression and cancer cell growth by targeting a Ras-linked coactivator.
    Asada S; Choi Y; Yamada M; Wang SC; Hung MC; Qin J; Uesugi M
    Proc Natl Acad Sci U S A; 2002 Oct; 99(20):12747-52. PubMed ID: 12242338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel epithelial-expressed ETS gene, ELF3: human and murine cDNA sequences, murine genomic organization, human mapping to 1q32.2 and expression in tissues and cancer.
    Tymms MJ; Ng AY; Thomas RS; Schutte BC; Zhou J; Eyre HJ; Sutherland GR; Seth A; Rosenberg M; Papas T; Debouck C; Kola I
    Oncogene; 1997 Nov; 15(20):2449-62. PubMed ID: 9395241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-cell ALL with SOX11 gene amplification associates with a worse outcome.
    Angelakakis G; Varkhedi M; Dabkowski TR; Diaz MJ; Yeagley M; Blanck G
    Cell Cycle; 2024 Jan; 23(1):36-42. PubMed ID: 38350028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HER2-Low Breast Cancer: Current Landscape and Future Prospects.
    Shirman Y; Lubovsky S; Shai A
    Breast Cancer (Dove Med Press); 2023; 15():605-616. PubMed ID: 37600670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ESE1/AGR2 axis antagonizes TGF-β-induced epithelial-mesenchymal transition in low-grade pancreatic cancer.
    Xu HJ; Bai J; Tian Y; Feng X; Chen AP; Wang J; Wu J; Jin XR; Zhang F; Quan MY; Chen C; Lee KY; Zhang JS
    Cancer Med; 2023 Mar; 12(5):5979-5993. PubMed ID: 36329620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interrupting specific hydrogen bonds between ELF3 and MED23 as an alternative drug resistance-free strategy for HER2-overexpressing cancers.
    Hwang SY; Park S; Jo H; Hee Seo S; Jeon KH; Kim S; Jung AR; Song C; Ahn M; Yeon Kwak S; Lee HJ; Uesugi M; Na Y; Kwon Y
    J Adv Res; 2023 May; 47():173-187. PubMed ID: 35963541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanopore Sequencing Unveils Diverse Transcript Variants of the Epithelial Cell-Specific Transcription Factor Elf-3 in Human Malignancies.
    Boti MA; Adamopoulos PG; Tsiakanikas P; Scorilas A
    Genes (Basel); 2021 May; 12(6):. PubMed ID: 34072506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXA1 and adaptive response determinants to HER2 targeted therapy in TBCRC 036.
    Angus SP; Stuhlmiller TJ; Mehta G; Bevill SM; Goulet DR; Olivares-Quintero JF; East MP; Tanioka M; Zawistowski JS; Singh D; Sciaky N; Chen X; He X; Rashid NU; Chollet-Hinton L; Fan C; Soloway MG; Spears PA; Jefferys S; Parker JS; Gallagher KK; Forero-Torres A; Krop IE; Thompson AM; Murthy R; Gatza ML; Perou CM; Earp HS; Carey LA; Johnson GL
    NPJ Breast Cancer; 2021 May; 7(1):51. PubMed ID: 33980863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-cell RNA sequencing reveals heterogeneous tumor and immune cell populations in early-stage lung adenocarcinomas harboring EGFR mutations.
    He D; Wang D; Lu P; Yang N; Xue Z; Zhu X; Zhang P; Fan G
    Oncogene; 2021 Jan; 40(2):355-368. PubMed ID: 33144684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound-mediated delivery of siESE complexed with microbubbles attenuates HER2+/- cell line proliferation and tumor growth in rodent models of breast cancer.
    Song KH; Trudeau T; Kar A; Borden MA; Gutierrez-Hartmann A
    Nanotheranostics; 2019; 3(2):212-222. PubMed ID: 31183315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ELF3, ELF5, EHF and SPDEF Transcription Factors in Tissue Homeostasis and Cancer.
    Luk IY; Reehorst CM; Mariadason JM
    Molecules; 2018 Aug; 23(9):. PubMed ID: 30200227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ESE-1/ELF3 mRNA expression associates with poor survival outcomes in HER2
    Kar A; Gutierrez-Hartmann A
    Oncotarget; 2017 Sep; 8(41):69622-69640. PubMed ID: 29050229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of EHF via gene amplification contributes to the activation of HER family signaling and associates with poor survival in gastric cancer.
    Shi J; Qu Y; Li X; Sui F; Yao D; Yang Q; Shi B; Ji M; Hou P
    Cell Death Dis; 2016 Oct; 7(10):e2442. PubMed ID: 27787520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of EHF contributes to thyroid tumorigenesis through transcriptionally regulating HER2 and HER3.
    Lv Y; Sui F; Ma J; Ren X; Yang Q; Zhang Y; Guan H; Shi B; Hou P; Ji M
    Oncotarget; 2016 Sep; 7(36):57978-57990. PubMed ID: 27517321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ESE1 is Associated with Neuronal Apoptosis in Lipopolysaccharide Induced Neuroinflammation.
    Feng Y; Xue H; Zhu J; Yang L; Zhang F; Qian R; Lin W; Wang Y
    Neurochem Res; 2016 Oct; 41(10):2752-2762. PubMed ID: 27350582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic Sequencing Identifies ELF3 as a Driver of Ampullary Carcinoma.
    Yachida S; Wood LD; Suzuki M; Takai E; Totoki Y; Kato M; Luchini C; Arai Y; Nakamura H; Hama N; Elzawahry A; Hosoda F; Shirota T; Morimoto N; Hori K; Funazaki J; Tanaka H; Morizane C; Okusaka T; Nara S; Shimada K; Hiraoka N; Taniguchi H; Higuchi R; Oshima M; Okano K; Hirono S; Mizuma M; Arihiro K; Yamamoto M; Unno M; Yamaue H; Weiss MJ; Wolfgang CL; Furukawa T; Nakagama H; Vogelstein B; Kiyono T; Hruban RH; Shibata T
    Cancer Cell; 2016 Feb; 29(2):229-40. PubMed ID: 26806338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-124 Regulates the Epithelial-Restricted with Serine Box/Epidermal Growth Factor Receptor Signaling Axis in Head and Neck Squamous Cell Carcinoma.
    Zhang M; Piao L; Datta J; Lang JC; Xie X; Teknos TN; Mapp AK; Pan Q
    Mol Cancer Ther; 2015 Oct; 14(10):2313-20. PubMed ID: 26227488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling age-related epigenetic markers of stomach adenocarcinoma in young and old subjects.
    Kim BC; Jeong HO; Park D; Kim CH; Lee EK; Kim DH; Im E; Kim ND; Lee S; Yu BP; Bhak J; Chung HY
    Cancer Inform; 2015; 14():47-54. PubMed ID: 25983541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.